Insulet | PODD - Net Income


Insulet reported $91.1M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Align Technology USD 112.77M 22.99M Mar/2026
AtriCure USD 108K 1.65M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Cardinal Health USD 399M 68M Mar/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Eli Lilly USD 7.4B 760M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Solventum Corp USD 13M 50M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
West Pharmaceutical Services USD 138.8M 6.7M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026